EN DE

Kwong Lung Enterprise Co (8916) Fair Value & Analysis

Consumer Cyclical · TW · Market cap 6.2B TWD

KL Kwong Lung Enterprise Co 8916 · TWO
Price43.25 TWD
Fair Value43.19 TWD
Upside-0.1%
Quality63/100
Watch Kwong Lung Enterprise Co for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 4.2% net margin
Low debt · generates free cash flow
5.90% dividend yield
Ranks above peers (9/14)
Narrow moat 31/100
Evidence: High Range 32.39 TWD – 54.65 TWD Share as image

Fair value as of: Jul 22, 2026

From 22 valuation models · updated 19 days ago

Share price −1.6% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from 32.39 TWD (bear) to 54.65 TWD (bull), base 43.19 TWD. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 63/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

55.91 TWD 27.66 TWD Fair Value 43.19 TWD Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range 27.66 TWD – 55.91 TWD · fair‑value band 32.39 TWD – 54.65 TWD · the 43.25 TWD price screens above the 43.19 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Kwong Lung Enterprise Co (8916) currently trades at 43.25 TWD, while our model-based Fair Value estimate is 43.19 TWD, implying the stock looks roughly 0.1% fairly valued today. The Quality Score stands at 63/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Kwong Lung Enterprise Co generated revenue of 8.3B TWD at a net margin of 4.2%. Revenue declined 13.3% year over year. It earns a return on equity of 6.8%. Net debt stands at 2.1B TWD. Fundamentals as of Jul 22, 2026

Our scenario range runs from 32.39 TWD (bear case) to 54.65 TWD (bull case); at 43.25 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -27% fair-value upside, at 0%, 8916 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 61.96 TWD 81.52 TWD 115.37 TWD 80
Residual Income 28.91 TWD 30.23 TWD 31.80 TWD 76
Rev-Margin DCF 41.30 TWD 56.49 TWD 76.00 TWD 74
All 22 models by family
DCF Models
FCF DCF 59.66 TWD 79.84 TWD 117.90 TWD 38
Owner Earnings 22.43 TWD 29.87 TWD 43.92 TWD 31
5Y Revenue Exit 41.30 TWD 55.09 TWD 75.54 TWD 39
5Y EBITDA Exit 45.35 TWD 62.01 TWD 84.62 TWD 41
5Y P/E Exit 45.75 TWD 62.69 TWD 83.52 TWD 38
10Y Revenue Exit 47.44 TWD 59.31 TWD 71.95 TWD 36
10Y EBITDA Exit 50.65 TWD 63.64 TWD 77.43 TWD 37
10Y P/E Exit 50.89 TWD 64.06 TWD 76.77 TWD 35
Earnings-Based
Graham-Dodd 17.28 TWD 24.89 TWD 29.28 TWD 54
EPV 21.41 TWD 24.69 TWD 27.52 TWD 59
Multiples
P/E Multiple 41.92 TWD 55.89 TWD 69.87 TWD 63
P/S Multiple 32.39 TWD 43.19 TWD 53.99 TWD 58
P/B Multiple 32.39 TWD 43.19 TWD 53.99 TWD 55
EV/EBIT 46.86 TWD 62.27 TWD 77.67 TWD 53
EV/EBITDA 41.81 TWD 55.53 TWD 69.25 TWD 54
EV/Revenue 31.80 TWD 45.15 TWD 58.50 TWD 43
Asset-Based
NCAV (Graham) 18.11 TWD 24.27 TWD 36.22 TWD 50
Growth DCF
Growth DCF 61.96 TWD 81.52 TWD 115.37 TWD 80
Rev-Margin DCF 41.30 TWD 56.49 TWD 76.00 TWD 74
Economic Profit
Residual Income 28.91 TWD 30.23 TWD 31.80 TWD 76
ROIC Compounder 21.41 TWD 24.69 TWD 27.52 TWD 72
Growth Earnings
Growth-Adj P/E 29.55 TWD 42.21 TWD 54.88 TWD 68

Widest divergence: DCF Models (62.01 TWD) versus Asset-Based (24.27 TWD). Highest evidence: Growth DCF (80).

Notify me when 8916 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 8.3B TWD
Revenue growth (YoY) -13.3%
Net margin 4.2%
Return on equity 6.8%
Free cash flow 930M TWD FY2025
P/E ratio 18.2
More key figures
Operating margin 0.1%
EPS (TTM) 2.47 TWD
Dividend yield 5.6%
EPS growth (YoY) -47.1%
Net debt 2.1B TWD FY2025

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 63/100

Of which business quality 63 · Market factors (momentum, volatility) 47

Profitability 37
Margins and returns on capital today
Quality Growth 41
Are margins and returns improving?
Cashflow 71
Earnings quality: real cash, not paper profit
Fin. Strength 67
Balance sheet, leverage, solvency risk
Investment 92
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 20
Distance to the 52-week high (market factor)
Net Issuance 86
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Kwong Lung Enterprise Co., Ltd. engages in the manufacture and sale of apparel in Taiwan, China, Vietnam, and Japan. It operates through Apparel Department, Down Material Department, and Home Textile Department segments.

Full company description

Kwong Lung Enterprise Co., Ltd. engages in the manufacture and sale of apparel in Taiwan, China, Vietnam, and Japan. It operates through Apparel Department, Down Material Department, and Home Textile Department segments. The company offers gore-tex garments; seam sealed; down jacket; padded outwear; sleeping bags; tents; and outdoor clothes and tactical pants for men and women. It also provides home textiles and bedding products to outdoor equipment; and down and feather products. The company was incorporated in 1966 and is headquartered in Taipei, Taiwan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Kwong Lung Enterprise Co reported revenue of 8.5B TWD in FY2025 versus 8.1B TWD in FY2021, a compound +1.4%/yr. Reported net income was 377M TWD in FY2025, compounding −7.5%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
8.5B TWD
Latest YoY
+8.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−6.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+0.1%
Avg. growth/yr (9Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−0.1%
Revenue +1.4%/yr
FY21 8.1B TWD
FY22 10.3B TWD
FY23 7.7B TWD
FY24 7.9B TWD
FY25 8.5B TWD
Net income −7.5%/yr
FY21 515M TWD
FY22 919M TWD
FY23 578M TWD
FY24 609M TWD
FY25 377M TWD

Watch 8916: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Kwong Lung Enterprise Co Fair Value". https://www.fairvalue-calculator.com/stock/8916

Peer Group

Textile Manufacturing · 307 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 63 · Top 25%
Fair Value upside −0% · Above median
Return on equity (TTM) 7% · Above median
Return on assets 3% · Above median
Net margin (TTM) 4% · Above median
Operating margin (TTM) 0% · Below median
Revenue growth -13% · Bottom 25%
Dividend yield (TTM) 5.9% · Top 25%
Debt / equity 0.14× · Higher than median

Valuation Multiples vs Textile Manufacturing median · lower = cheaper

P/E (TTM) 17.0× · Cheaper than median
P/B 1.16× · Pricier than median
P/S (TTM) 0.75× · Cheaper than median
P/FCF 0.2× · Cheaper than median
EV/EBITDA 10.7× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 33 · sector 8
FUTURE 0 · sector 0
PAST 27 · sector 15
HEALTH 93 · sector 95
DIVIDEND 100 · sector 34

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
Shenzhou International Group 2313 HK$44.40 HK$75.65 +70%
Tongkun Group 601233 ¥23.56 ¥14.53 -38%
Inner Mongolia ERDOS Resources Co 600295 ¥12.04 ¥14.35 +19%
HMT (Xiamen) New Technical Materials Co 603306 ¥91.75 ¥12.85 -86%
Far Eastern New Century Corporation 1402 27.55 TWD 28.72 TWD +4%
K.P.R. Mill Limited KPRMILL ₹1,083 ₹467.49 -57%
Zhejiang Orient Holdings 600120 ¥5.18 ¥2.21 -57%
Vardhman Textiles Limited VTL ₹602.20 ₹437.53 -27%
Isiklar Enerji ve Yapi Holding IEYHO 174.20 TRY 323.84 TRY +86%
Shandong Fiberglass Group 605006 ¥16.75 ¥6.42 -62%

Compare Kwong Lung Enterprise Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Kwong Lung Enterprise Co (8916) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of 43.19 TWD versus a price of 43.25 TWD, about −0% (fairly valued).
What is the fair value of 8916?
Our model-based fair value for Kwong Lung Enterprise Co is 43.19 TWD (as of Jul 22, 2026), built from audited fundamentals. The current price is 43.25 TWD.
What is the quality score of 8916?
Kwong Lung Enterprise Co has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Kwong Lung Enterprise Co (8916)?
Kwong Lung Enterprise Co reported trailing-twelve-month revenue of about 8.3B TWD (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 8916?
The net profit margin of Kwong Lung Enterprise Co is about 4.2%, meaning it keeps roughly 4.2% of revenue as net income. Based on the latest reported figures.
Does Kwong Lung Enterprise Co pay a dividend?
Kwong Lung Enterprise Co currently shows a dividend yield of about 5.57% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Kwong Lung Enterprise Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.